# Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection

> **NCT05948592** · PHASE2 · COMPLETED · sponsor: **Technophage, SA** · enrollment: 76 (actual)

## Conditions studied

- Diabetic Foot Infection

## Interventions

- **BIOLOGICAL:** TP-102
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05948592
- **Lead sponsor:** Technophage, SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-08
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-12-19
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948592, "Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT05948592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*